While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma? Mepolizumab use significantly reduced the use of oral ...
An intensive training schedule is linked to a heightened risk of non-allergic asthma in competitive cross-country skiers, finds research published in the open access journal BMJ Open Sports & Exercise ...
Please provide your email address to receive an email when new articles are posted on . The prevalence of non-allergic asthma was elevated among successful competitive cross-country skiers compared ...
A new study concludes that the risk is higher among those with non-allergic asthma, of longer disease duration or under treatment with corticosteroids "Several studies have shown that asthma and ...
Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Day two of the 2023 American Academy of Allergy, Asthma & Immunology Annual Meeting was very busy ...
The combination of smoking and socioeconomic status (SES) is associated with risk of asthma among different socio-occupational groups, this new study found. In addition to independent risk factors, ...
PHOENIX -- Patients with severe, uncontrolled asthma experienced greater relief throughout the year when treated with the biologic tezepelumab (Tezspire) versus placebo, according to findings from the ...
NEW YORK (Reuters Health) - Mold exposure in the home raises the risk of asthma symptoms in middle age, according to a new study from Australia. The more mold participants reported having seen in ...
The study is the first to find an association between adults with asthma and the risk of obesity developing later. Adults with asthma are more likely to become obese later in life, and the risk is ...
Black children are three times as likely as their white counterparts to develop asthma. A recent finding points to genetics as a possible explanation. A study conducted at Henry Ford Health identified ...
Asthma diagram, lungs The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results